Tekla Life Sciences Inves... (HQL)
NYSE: HQL
· Real-Time Price · USD
13.93
0.02 (0.14%)
At close: Aug 29, 2025, 3:59 PM
14.08
1.11%
After-hours: Aug 29, 2025, 05:16 PM EDT
Tekla Life Sciences Investors Revenue
Tekla Life Sciences Investors reported an annual revenue of $86.69M, reflecting a 120.1% growth. For the quarter ending March 31, 2025, Tekla Life Sciences Investors generated $18.2M in revenue.
Revenue (ttm)
86.69M
Revenue Growth
120.1%
Price / Sales Ratio
4.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
402.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Sep 30, 2024 | 86.69M | +120.10% |
| Sep 30, 2023 | 39.39M | +23.61% |
| Sep 30, 2022 | 31.86M | -29.23% |
| Sep 30, 2021 | 45.02M | +15.23% |
| Sep 30, 2020 | 39.07M | +1500.91% |
| Sep 30, 2019 | 2.44M | +22.90% |
| Sep 30, 2018 | 1.99M | -97.16% |
| Sep 30, 2017 | 69.81M | +1009.65% |
| Sep 30, 2016 | 6.29M | +375.68% |
| Sep 30, 2015 | 1.32M | +50.85% |
| Sep 30, 2014 | 876.79K | +69.67% |
| Sep 30, 2013 | 516.76K | -75.90% |
| Sep 30, 2012 | 2.14M | +276.23% |
| Sep 30, 2011 | 570K | -68.68% |
| Sep 30, 2010 | 1.82M | +295.65% |
| Sep 30, 2009 | 460K | -72.46% |
| Sep 30, 2008 | 1.67M | -42.01% |
| Sep 30, 2007 | 2.88M | +25.22% |
| Sep 30, 2006 | 2.3M | +158.43% |
| Sep 30, 2005 | 890K | +178.13% |
| Sep 30, 2004 | 320K | -47.54% |
| Sep 30, 2003 | 610K | -35.11% |
| Sep 30, 2002 | 940K | -46.89% |
| Sep 30, 2001 | 1.77M | +1164.29% |
| Sep 30, 1998 | 140K | -56.25% |
| Sep 30, 1997 | 320K | -23.81% |
| Sep 30, 1996 | 420K | n/a |